(Q41017702)

25 September 2017

title

Antitumor activity with the HSV-tk-gene-modified cell line PA-1-STK in malignant mesothelioma (English)

1 reference

25 September 2017

7

Summer W

1 reference

25 September 2017

Schwarzenberger P

1

1 reference

25 September 2017

Lei D

2

1 reference

25 September 2017

Freeman SM

3

1 reference

25 September 2017

Ye P

4

1 reference

25 September 2017

Weinacker A

5

1 reference

25 September 2017

Theodossiou C

6

1 reference

25 September 2017

Kolls JK

8

1 reference

25 September 2017

publication date

1 August 1998

1 reference

American Journal of Respiratory Cell and Molecular Biology

25 September 2017

published in

1 reference

25 September 2017

volume

19

1 reference

25 September 2017

issue

2

1 reference

25 September 2017

page(s)

333-337

1 reference

Analysis of current trends in United States mesothelioma incidence

25 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.19.2.3123

Malignant mesothelioma: new insights into tumour biology and immunology as a basis for new treatment approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.19.2.3123

Treatment of pleural mesothelioma in an immunocompetent rat model utilizing adenoviral transfer of the herpes simplex virus thymidine kinase gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.19.2.3123

Successful adenovirus-mediated gene transfer in an in vivo model of human malignant mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.19.2.3123

Treatment of experimental human mesothelioma using adenovirus transfer of the herpes simplex thymidine kinase gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.19.2.3123

Gene therapy using adenovirus carrying the herpes simplex-thymidine kinase gene to treat in vivo models of human malignant mesothelioma and lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.19.2.3123

The role of immunosuppression in the efficacy of cancer gene therapy using adenovirus transfer of the herpes simplex thymidine kinase gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.19.2.3123

The extent of heterocellular communication mediated by gap junctions is predictive of bystander tumor cytotoxicity in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.19.2.3123

The role of cytokines in mediating the bystander effect using HSV-TK xenogeneic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.19.2.3123

Immune system in suicide-gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.19.2.3123

Establishment of a murine model of malignant mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.19.2.3123

Prolonged and effective blockade of tumor necrosis factor activity through adenovirus-mediated gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.19.2.3123

Pleural-based mesothelioma in immune competent rats: a model to study adenoviral gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.19.2.3123

Bystander killing of cancer cells by herpes simplex virus thymidine kinase gene is mediated by connexins

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.19.2.3123

21 January 2018

Identifiers

DOI

10.1165/AJRCMB.19.2.3123

1 reference

25 September 2017

1 reference